Search research articles
Contact Us
Filters
Showing results (211-220 of 259) with videos related to
Page
of 26
Sort By:
British Journal of Cancer
|
February 5, 2009
Dietary glycemic load and gastric cancer risk in Italy
P Bertuccio, D Praud, L Chatenoud, et al.
Transplantation
|
June 1, 1986
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent
P Vigeral, N Chkoff, L Chatenoud, et al.
European Cytokine Network
|
July 1, 1995
Role of interleukin-2 receptors in the suppressive effect of spleen cells from anti-CD3-treated mice
A Ben-Amor, Leite-De-Moraes MdC, F Lepault, et al.
The American Journal of Clinical Nutrition
|
December 3, 1999
Refined-cereal intake and risk of selected cancers in italy
L Chatenoud, C La Vecchia, S Franceschi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 23, 2014
Quantification of circulating house dust mite-specific IL-4- and IL-13-secreting T cells correlates with rhinitis severity in asthmatic children and varies with the seasons
B Michaud, R Gouvis-Echraghi, S Candon, et al.
Transplantation Proceedings
|
February 1, 1990
First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization
S A Birkeland, J F Bach, L Chatenoud, et al.
Transplantation Proceedings
|
February 1, 1989
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection
H Kreis, N Chkoff, L Chatenoud, et al.
Transplantation
|
February 1, 1984
Nonsteroid antiinflammatory agents as a substitute treatment for steroids in ATGAM-treated cadaver kidney recipients
H Kreis, N Chkoff, D Droz, et al.
Nephrologie
|
January 1, 1987
[Preventive treatment of rejection by the prolonged administration of OKT3: decrease of the immune response of the host]
A Debure, N Chkoff, L Chatenoud, et al.
Kidney International
|
October 1, 1989
In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients
G Beaurain, C Naret, L Marcon, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 259) with videos related to
Sort By:
Page
of 26
British Journal of Cancer
|
February 5, 2009
Dietary glycemic load and gastric cancer risk in Italy
P Bertuccio, D Praud, L Chatenoud, et al.
Transplantation
|
June 1, 1986
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent
P Vigeral, N Chkoff, L Chatenoud, et al.
European Cytokine Network
|
July 1, 1995
Role of interleukin-2 receptors in the suppressive effect of spleen cells from anti-CD3-treated mice
A Ben-Amor, Leite-De-Moraes MdC, F Lepault, et al.
The American Journal of Clinical Nutrition
|
December 3, 1999
Refined-cereal intake and risk of selected cancers in italy
L Chatenoud, C La Vecchia, S Franceschi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 23, 2014
Quantification of circulating house dust mite-specific IL-4- and IL-13-secreting T cells correlates with rhinitis severity in asthmatic children and varies with the seasons
B Michaud, R Gouvis-Echraghi, S Candon, et al.
Transplantation Proceedings
|
February 1, 1990
First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization
S A Birkeland, J F Bach, L Chatenoud, et al.
Transplantation Proceedings
|
February 1, 1989
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection
H Kreis, N Chkoff, L Chatenoud, et al.
Transplantation
|
February 1, 1984
Nonsteroid antiinflammatory agents as a substitute treatment for steroids in ATGAM-treated cadaver kidney recipients
H Kreis, N Chkoff, D Droz, et al.
Nephrologie
|
January 1, 1987
[Preventive treatment of rejection by the prolonged administration of OKT3: decrease of the immune response of the host]
A Debure, N Chkoff, L Chatenoud, et al.
Kidney International
|
October 1, 1989
In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients
G Beaurain, C Naret, L Marcon, et al.
Page
of 26